Skip to content

Clinical trials

Phase 2/3 Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2/3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20071
20111
20123
20131
20143
20151
20171
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Nutrition and Food Technology Institute4
Dr Azita Hekmatdoost2
Alexion Pharmaceuticals, Inc.1
Bambino Gesù Hospital and Research Institute1
Galectin Therapeutics Inc.1
Indiana University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northwestern University1
Russian Academy of Medical Sciences1
Shiraz University of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease18
Fatty Liver3
Diabetes Mellitus, Type 22
Fibrosis2
Insulin Resistance2
Cholesterol Ester Storage Disease1
Esophageal and Gastric Varices1
Hepatitis1
Hypertension, Portal1
Inflammation1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.